Free Trial
OTCMKTS:MEOBF

Mesoblast (MEOBF) Stock Price, News & Analysis

Mesoblast logo
$0.97 0.00 (0.00%)
As of 07/17/2025

About Mesoblast Stock (OTCMKTS:MEOBF)

Key Stats

Today's Range
$0.97
$0.97
50-Day Range
$0.96
$1.44
52-Week Range
$0.56
$5.34
Volume
N/A
Average Volume
133,747 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Mesoblast Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
0th Percentile Overall Score

MEOBF MarketRank™: 

Mesoblast scored higher than 0% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Mesoblast.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Mesoblast is -3.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Mesoblast is -3.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Mesoblast's valuation and earnings.
  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Mesoblast has a short interest ratio ("days to cover") of 216847.5, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Mesoblast has recently decreased by 2.96%, indicating that investor sentiment is improving.
  • Dividend Yield

    Mesoblast does not currently pay a dividend.

  • Dividend Growth

    Mesoblast does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Mesoblast has a short interest ratio ("days to cover") of 216847.5, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Mesoblast has recently decreased by 2.96%, indicating that investor sentiment is improving.
  • News Sentiment

    Mesoblast has a news sentiment score of -0.80. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.96 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Mesoblast this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Mesoblast insiders have not sold or bought any company stock.

  • Percentage Held by Institutions

    Only 27.35% of the stock of Mesoblast is held by institutions.

  • Read more about Mesoblast's insider trading history.
Receive MEOBF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mesoblast and its competitors with MarketBeat's FREE daily newsletter.

MEOBF Stock News Headlines

The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
See More Headlines

MEOBF Stock Analysis - Frequently Asked Questions

Mesoblast's stock was trading at $2.20 on January 1st, 2025. Since then, MEOBF shares have decreased by 56.1% and is now trading at $0.9650.

Shares of MEOBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
7/18/2025
Next Earnings (Estimated)
7/29/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:MEOBF
CIK
1345099
Fax
N/A
Employees
80
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (OTCMKTS:MEOBF) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners